ADMA BIOLOGICS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adma Biologics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Adma Biologics, Inc. Return On Equity for the quarter ending September 30, 2024 was 38.4 %.
  • Adma Biologics, Inc. annual Return On Equity for 2023 was -19.5 %, a 63.5% increase from 2022.
  • Adma Biologics, Inc. annual Return On Equity for 2022 was -53.4 %, a 12.8% increase from 2021.
  • Adma Biologics, Inc. annual Return On Equity for 2021 was -61.2 %, a 32.7% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 38.4 +53.8 Jul 1, 2024 Sep 30, 2024
Q2 2024 22.1 +51.7 Apr 1, 2024 Jun 30, 2024
Q1 2024 -2.48 +34.7 +93.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.5 +33.9 +63.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -15.3 +42.9 +73.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -29.6 +30.7 +50.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -37.2 +27.7 +42.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -53.4 +7.83 +12.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -58.3 +13.4 +18.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -60.3 +16.5 +21.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -64.9 +20.9 +24.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -61.2 +29.8 +32.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -71.7 +27.1 +27.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -76.7 +27.6 +26.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -85.8 +20.2 +19% Jan 1, 2021 Mar 31, 2021
Q4 2020 -91 +70.9 +43.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -98.8 +98.8 +50% Jul 1, 2020 Sep 30, 2020
Q2 2020 -104 +104 +50% Apr 1, 2020 Jun 30, 2020
Q1 2020 -106 +99.4 +48.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -162 +37.7 +18.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -198 -38.3 -24% Jul 1, 2019 Sep 30, 2019
Q2 2019 -209 -19.1 -10% Apr 1, 2019 Jun 30, 2019
Q1 2019 -205 +6.25 +2.95% Jan 1, 2019 Mar 31, 2019
Q4 2018 -200 +49.6 +19.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -159 +396 +71.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -190 +605 +76.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -212 -961 -128% Jan 1, 2018 Mar 31, 2018
Q4 2017 -249 -2.17K -113% Oct 1, 2017 Dec 31, 2017
Q3 2017 -555 +5.87K +91.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -795 +499 +38.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 749 +1.39K Jan 1, 2017 Mar 31, 2017
Q4 2016 1.92K +2.17K Oct 1, 2016 Dec 31, 2016
Q3 2016 -6.43K -6.23K -3112% Jul 1, 2016 Sep 30, 2016
Q2 2016 -1.29K -1.13K -711% Apr 1, 2016 Jun 30, 2016
Q1 2016 -639 -497 -351% Jan 1, 2016 Mar 31, 2016
Q4 2015 -251 -95.8 -61.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -200 -78.5 -64.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -159 -18.8 -13.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -142 +47.5 +25.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -155 +59.7 +27.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -122 +189 +60.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -141 +46.3 +24.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -189 -94.6 -100% Jan 1, 2014 Mar 31, 2014
Q4 2013 -214 -158 -278% Oct 1, 2013 Dec 31, 2013
Q3 2013 -311 -185 -146% Jul 1, 2013 Sep 30, 2013
Q2 2013 -187 -42.7 -29.5% Apr 1, 2013 Jun 30, 2013
Q1 2013 -94.5 +210 +69% Jan 1, 2013 Mar 31, 2013
Q4 2012 -56.8 Oct 1, 2012 Dec 31, 2012
Q3 2012 -126 Jul 1, 2012 Sep 30, 2012
Q2 2012 -144 Apr 1, 2012 Jun 30, 2012
Q1 2012 -305 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.